Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12624000417583
Ethics application status
Approved
Date submitted
17/08/2023
Date registered
5/04/2024
Date last updated
21/07/2024
Date data sharing statement initially provided
5/04/2024
Type of registration
Prospectively registered
Titles & IDs
Public title
A pilot randomised controlled trial assessing feasibility, acceptability, preliminary efficacy and cost-effectiveness of RecoverEsupport Breast: A Digital health intervention to support breast cancer patients in their preparation for and recovery from surgery.
Query!
Scientific title
A pilot randomised controlled trial assessing feasibility, acceptability, preliminary efficacy and cost-effectiveness of RecoverEsupport Breast: A Digital health intervention to support breast cancer patients in their preparation for and recovery from surgery.
Query!
Secondary ID [1]
310349
0
Nil known
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Breast Cancer
331081
0
Query!
Condition category
Condition code
Cancer
327871
327871
0
0
Query!
Breast
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
The RecoverEsupport Digital Health Intervention:
OVERVIEW: RecoverEsupport is a digital health intervention to support patients to prepare for and recover from breast cancer surgery. The RecoverEsupport intervention is a multicomponent intervention based around a purpose-built online program. It is designed to be used pre-surgery, post-surgery and post-discharge, and focuses primarily on patient-managed behaviours to enhance their preparation for and recovery from surgery. Specifically, it supports patients to adhere to the evidence-based patient-led ERAS (Enhanced Recovery After Surgery) recommendations to optimise their recovery. Recommended behaviours include early mobilisation, early oral diet, early fluids, minimisation of opioids and physio exercises.
What: In addition to the online program, the RecoverEsupport intervention also includes provision of patient prompts (to access the online program and to remind them of, and to monitor and record their behaviours), and clinician prompts (alerting nursing staff when patients are not adhering to the ERAS recommendations).
Procedures: The intervention includes a variety of evidence-based behaviour change strategies as described in the framework by Wang et al for classifying digital health interventions for behaviour change (2019 JMIR). These strategies include: Self-monitoring and feedback; Instruction on how to perform the target behaviours; Provision of information about health consequences; Provision of information from a credible source; Demonstration of behaviour; Provision of Prompts/cues.
Strategies are operationalised through: daily diaries with feedback (provided to the patients and clinical team) and automatic non-compliance alerts provided to the clinical team; prompts and reminders to access the online program and complete the daily diaries; and provision of information via the online program in the form of text, videos, diagrams and quiz questions.
How: (Delivery Mode) Intervention content will be provided via an online program, SMS and email. The device the intervention is accessed on is at the discretion of the participant (computer, tablet, or smartphone). To increase patient participation during their hospital stay, they will be encouraged to bring their tablet or laptop with them. Patients without access to a tablet or laptop will have one provided during their hospital stay.
Who: Embedded in the online program are a series of informational videos which are delivered by clinicians (the Surgeon, Anaesthetist, Breast Care Nurses, Exercise Physiologist). The intervention prompts are ostensibly from members of the clinical team. The nurse receives a prompt when patients are not adhering to the targeted patient-led ERAS recommendations.
Where: The online program has been designed to be accessed in the home (or wherever most convenient for the participants) during the pre-surgical and post-discharge phases and designed to be accessed in the hospital post-surgery.
When and how much: The online program will be accessible on-demand for the patient throughout the trial. It is suggested that participants log on to the online program as many times as they need in the pre-surgical phase. Post-surgery, during their hospital stay, they will be prompted daily to access the online program and monitor and record their behaviour. The intervention group will have access to the RecoverEsupport program from the time they complete the baseline surveys (approx. 2 weeks pre-surgery) until 3 months post-surgery.
The duration of engagement will be at the discretion of the participant; however, it is envisaged that participants will spend approximately 1-2 hours using the online program before their surgery, and then approximately 5-10 minutes each day in hospital following their surgery, and then approximately 10 minutes per day for the following 4 weeks.
Tailoring: Patients will receive tailored feedback from within the online program and (if applicable) from the nurse as a result of the monitoring of their daily behaviours.
How well: Use and access to the online program will be tracked through analytics to allow assessment of intervention fidelity.
As yet, there have been no modifications to the registered protocol.
Query!
Intervention code [1]
326747
0
Treatment: Other
Query!
Intervention code [2]
326748
0
Rehabilitation
Query!
Intervention code [3]
326749
0
Behaviour
Query!
Comparator / control treatment
Usual Care: All patients will receive usual care regarding preparation for and recovery from surgery.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
335717
0
Feasibility of the RecoverEsupport intervention will be assessed based on the following pre-specified targets:
(1) Participant recruitment (Target: N=70 participants consent to the study)
(2) Retention rate (Target: >85% remain in the study at 1 month follow-up (i.e. have not withdrawn)
(3) Data collection (Target: >85% of participants from the study have Length of Stay data collected)
(4) Adverse events (Target – no adverse events classified as Grade 3 or above, based on items that have been adapted from the Common Terminology Criteria for Adverse Events including falls, muscle pain/discomfort, and anxiety)
Acceptability of the RecoverEsupport intervention will assessed among intervention participants (only), and will be based on the following:
(1) Intervention usability (Target: Average score on the System Usability Scale >68 i.e. Okay” or higher), measured at 1-month post-surgery.
(2) Intervention engagement: Use of ‘RecoverEsupport’, measured at 1-month and 3-months post-surgery. Use of the online program will be monitored through analytics automatically recorded by REDcap.
(3) Intervention component acceptability: A series of questions using Likert scale response options will assess the acceptability of characteristics of the intervention components, measured at 1-month post-surgery.
Query!
Assessment method [1]
335717
0
Query!
Timepoint [1]
335717
0
1 and 3-month post surgery
Query!
Primary outcome [2]
337623
0
Preliminary efficacy:
Length of Stay: Reported in Days and hours, as recorded by Local Health District Medical Records (MR) data.
Query!
Assessment method [2]
337623
0
Query!
Timepoint [2]
337623
0
At hospital discharge
Query!
Secondary outcome [1]
432567
0
Quality of life (QoL) assessed via the EORTC QLQ-C30
Query!
Assessment method [1]
432567
0
Query!
Timepoint [1]
432567
0
Measured at Baseline, 1- & 3-months post-surgery
Query!
Secondary outcome [2]
432568
0
Quality of Recovery (QoR) assessed via the QOR-15
Query!
Assessment method [2]
432568
0
Query!
Timepoint [2]
432568
0
Measured post-operatively (in hospital), and at 1- & 3-months post-surgery.
Query!
Secondary outcome [3]
432569
0
Anxiety assessed via The Hospital Anxiety and Depression Scale (HADS)
Query!
Assessment method [3]
432569
0
Query!
Timepoint [3]
432569
0
Assessed at baseline, 1-month and 3-months post-surgery.
Query!
Secondary outcome [4]
432570
0
Patient behaviours related to patient-managed ERAS recommendations (pre-admission behaviours and mobilisation, oral diet, fluid intake, opioid minimisation, and physio exercises), assessed via questions developed specifically for the study,
Query!
Assessment method [4]
432570
0
Query!
Timepoint [4]
432570
0
Measured post-operatively (in hospital).
Query!
Secondary outcome [5]
432571
0
Hospital re-admissions and Emergency Department visits assessed via Local Health District Medical Records data and an adapted version of the Client Service Receipt Inventory (CSRI). (A clinician will review the re-admissions/visits to identify those that are related to breast surgery).
Query!
Assessment method [5]
432571
0
Query!
Timepoint [5]
432571
0
Measured at 3-months post-surgery.
Query!
Secondary outcome [6]
432572
0
Health Service utilisation post-discharge: assessed via an adapted version of the Client Service Receipt Inventory (CSRI),
Query!
Assessment method [6]
432572
0
Query!
Timepoint [6]
432572
0
Measured at 3-months post-surgery.
Query!
Secondary outcome [7]
432573
0
The intervention cost, cost consequence and cost-effectiveness.
Query!
Assessment method [7]
432573
0
Query!
Timepoint [7]
432573
0
Cost data will be collected throughout the duration of the intervention based on detailed project management records, assessed at the conclusion of the study at 3 months post-surgery.
Query!
Eligibility
Key inclusion criteria
Patients aged 18+ years with a planned mastectomy with or without a breast reconstruction for breast cancer; or a reconstruction following a mastectomy; English speaking; cognitively and emotionally able to participate; have internet access and who have access to an email address or phone that can receive SMS messages.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Patients who are unable to provide independent informed consent; those under 18 years of age; patients having 'autologus' reconstructions (DIEP/TRAM/LDs), those who have previously participated in this study, and those who require emergency surgery.
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation is concealed through use of central randomisation by computer
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
The randomisation will be programmed by an independent statistician using REDcap software with block sizes varying randomly from 4 to 6.
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Blinding of participants to group allocation will not be possible for this trial, as both the participant and nursing staff will be aware of whether the person is receiving the intervention.
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Length of stay, hospital admissions and ED visits, will be modelled using general linear models. Fixed effects will be included for treatment group and baseline QoL.
QoL, QoR, and anxiety will be modelled using generalised linear mixed models. Fixed effects will be included for treatment group, time point, the interaction between treatment group and time, and baseline QoL / QoR, and a random effect for participant ID will be included to account for the repeated measures on individuals.
All analyses will be conducted with the Bayesian Framework using non-informative priors. Effect measures will be reported as the mean difference between the treatment groups (and 95% Credible Intervals), or Incident Rate Ratios (IRR) and 95% Credible Intervals, alongside the posterior probability of a treatment effect, and Bayes Factors will be calculated a measure of evidence against the null.
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
8/07/2024
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
31/12/2025
Query!
Actual
Query!
Date of last data collection
Anticipated
31/03/2026
Query!
Actual
Query!
Sample size
Target
70
Query!
Accrual to date
0
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
NSW
Query!
Recruitment hospital [1]
25354
0
Calvary Mater Newcastle - Waratah
Query!
Recruitment postcode(s) [1]
41083
0
2298 - Waratah
Query!
Funding & Sponsors
Funding source category [1]
314555
0
Other
Query!
Name [1]
314555
0
Cancer Council NSW: Early Career Development Fellowship (2021/ECF1355)
Query!
Address [1]
314555
0
153 Dowling StWoolloomooloo NSW 2011
Query!
Country [1]
314555
0
Australia
Query!
Primary sponsor type
University
Query!
Name
University of Newcastle
Query!
Address
University Drive, Callaghan NSW 2308, Australia
Query!
Country
Australia
Query!
Secondary sponsor category [1]
316513
0
None
Query!
Name [1]
316513
0
Query!
Address [1]
316513
0
Query!
Country [1]
316513
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
313592
0
Hunter New England Human Research Ethics Committee
Query!
Ethics committee address [1]
313592
0
HNE Research Office, Locked Bag 1, New Lambton NSW 2305
Query!
Ethics committee country [1]
313592
0
Australia
Query!
Date submitted for ethics approval [1]
313592
0
31/10/2022
Query!
Approval date [1]
313592
0
15/12/2022
Query!
Ethics approval number [1]
313592
0
2022/ETH02010
Query!
Summary
Brief summary
This randomised controlled pilot trial will test the feasibility, acceptability, preliminary efficacy and cost-effectiveness of a digital health intervention (RecoverEsupport) among breast cancer patients undergoing surgery. Who is it for? You may be eligible for this trial if you are aged between 18 years or older, have been diagnosed with breast cancer, and are planning to undergo mastectomy with or without a breast reconstruction, or a breast reconstruction (following a previous mastectomy) Study details Eligible patients will be recruited at the pre-surgical consultation or the peri-operative clinic. Consenting patients will be asked to complete surveys at: baseline, post-surgery during the hospital admission, and post-discharge (1- and 3-months post-surgery). Following completion of the baseline survey, patients will be randomly allocated to the control group (receiving standard care), or the intervention group (receiving the RecoverEsupport program): RecoverEsupport is a digital health intervention aimed at improving adherence to patient-led ERAS recommendations. The intervention includes an online program (accessible to patients) and a series of prompts for patients and clinicians to encourage continued self-management. It is hoped this intervention will assist in overcoming some of the barriers to implementation of the ERAS pathway. If effective, the intervention could be rapidly rolled-out at scale and adapted for other surgical patient groups.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
128674
0
A/Prof Rebecca Wyse
Query!
Address
128674
0
University of Newcastle Lot 1 Kookaburra Cct, New Lambton Heights NSW 2305
Query!
Country
128674
0
Australia
Query!
Phone
128674
0
+61 2 4042 0272
Query!
Fax
128674
0
Query!
Email
128674
0
[email protected]
Query!
Contact person for public queries
Name
128675
0
Emma Sansalone
Query!
Address
128675
0
University of Newcastle Lot 1 Kookaburra Cct, New Lambton Heights NSW 2305
Query!
Country
128675
0
Australia
Query!
Phone
128675
0
+61 2 4042 0964
Query!
Fax
128675
0
Query!
Email
128675
0
[email protected]
Query!
Contact person for scientific queries
Name
128676
0
Emma Sansalone
Query!
Address
128676
0
University of Newcastle Lot 1 Kookaburra Cct, New Lambton Heights NSW 2305
Query!
Country
128676
0
Australia
Query!
Phone
128676
0
+61 2 4042 0964
Query!
Fax
128676
0
Query!
Email
128676
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
IPD will not be available as we do not have ethical permission to share data at this level.
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Doc. No.
Type
Citation
Link
Email
Other Details
Attachment
19966
Study protocol
[email protected]
Available through contacting the contact person fo...
[
More Details
]
19967
Ethical approval
[email protected]
Available through contacting the contact person fo...
[
More Details
]
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF